REFERENCES
- Bunting K. D. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002; 20: 11–20
- Wei L., Cui L., Snider B. J., Rivkin M., Yu S. S., Lee C. S., Adams L. D., Gottlieb D. I., Johnson E. M., Yu S. P., Choi D. W. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol Dis 2005; 19: 183–193
- Wicha M. S., Liu S., Dontu G. Cancer stem cells; an old idea-a paradigm shift. Cancer Res 2005; 66: 1883–1890
- Yamane T., Dylla S. J., Muijtjens M., Weissman I.L. Enforced Bcl-2 expression overrides serum and feeder cell requirements for mouse embryonic stem cell self-renewal. Proc Natl Acad Sci US 2005; 102: 3312–3317
- Zhou S., Schuetz J. D., Bunting K. D., Colapietro A. M., Sampath J., Morris J. J., Lagutina I., Grosveld G. C., Osawa M., Nakauchi H., Sorrentino B. P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7: 1028–1034
- Singh S. K., Clarke I.D, Terasaki M., Bonn V. E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821–5828
- Yuan X., Curtin J., Xiong Y., Liu G., Waschsmann-Hogiu S., Farkas D. L., Black K.L, Yu J. S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004; 23: 9392–9400
- Singh S. K., Hawkins C., Clarke I. D., Squire J., Bayani J., Hide T., Henkelman R. M., Cusimano M. D., Dirks P. B. Identification of human brain tumor initiating cells. Nature 2004; 432: 396–401
- Liu G., Yuan X., Zeng Y., Tunici P., Ng. H., Abdulkadir I. R., Lu L., Irvin D., Black K.L, Yu J. S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67
- Miller S. J., Lavker R. M., Sun T.T. Interpreting epithelial cancer biology in the context of stem cells; tumor properties and therapeutic implications. Biochim Biophys Acta 2005; 1756: 25–52
- Schiffer D., Manazza A., Tamagno I. Nestin expression in neuroepithelial tumors. Neurosci Lett 2006; 400: 80–85
- Cheong H. T., Park T. M., Ikeda K., Takahashi Y. Cell cycle analysis of bovine cultured somatic cells by flow cytometry. Jpn J Vet Res 2003; 51: 95–103
- Dean M., Fojo T., Bates S. Tumor stem cells and drug resistance. Nat Rev Cancer 2005; 5: 275–284
- Grskovic B., Ruzicka K., Karimi A., Qujeg D., Muller M. M. Cell cycle analysis of the CD133+ and CD133− cells isolated from umbilical cord blood. Clin Chim Acta 2004; 343: 173–178
- Galderisi U., Cipollaro M., Giordano A. Stem cells & brain cancer. Cell Death Differ 2006; 13: 5–11
- Mehrian S. R., Reichardt J. K., Ya-Hsuan H., Kremen T. J., Liau L. M., Cloughesy T. F., Mischel P. S., Nelson S. F. Robustness of gene expression profiling in glioma specimen samplings and derived cell lines. Brain Res Mol Brain Res 2005; 136: 99–103
- Miyashita T., Reed J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993; 81: 151–157
- Donnenberg V. S., Donnenberg A. D. Multiple drug resistance in cancer revisited; the cancer stem cell hypothesis. J Clin Pharmacol 2005; 45: 872–877
- Leonard G. D., Fojo D., Bates S. E. The role of ABC transporters in clinical practice. Oncologist 2003; 8: 411–424
- Reya T., Morrison S. J., Clarke M. F. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105–111
- Domen J., Weissman I. L. Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J Exp Med 2000; 192: 1707–1718
- Almqvist P. M., Mah R., Lendahl R., Jacobsson R., Hendson G. Immunohistochemical detection of nestin in pediatric brain tumors. J Histochem Cytochem 2000; 50: 147–158